Oral Solid Dose (OSD)
- Bottles, blisters, and specialty formats
- High-volume commercial runs and flexible batch sizes
- Serialization and global market compliance
When Demand Outpaces Internal Packaging Capacity
Scale Confidently With PCI Pharma Services
Commercial drug products often reach a point where forecast demand outpaces internal packaging capabilities. Launch timelines remain fixed, patient need continues to grow, and internal resources are already fully allocated. At that moment, packaging capacity becomes a strategic constraint. PCI Pharma Services removes that constraint.
Global Commercial Packaging Capacity Available When You Need It.
Our UK, EU, Canada and US facilities are purpose-built for commercial scale, with the quality systems, regulatory track record, and operational rigor required by global clients and regulatory authorities alike. PCI offers scalable commercial packaging capacity across our global network for:
Injectable Drug Products
- Syringes, vials, cartridges, and combination products
- Specialist assembly, testing and packaging of drug-device combination products
- Complex secondary packaging and labeling
- Support for cold chain and high-value biologics
Build vs. Buy: A Strategic Decision - Not Just a Capacity Gap
When internal capacity is stretched, expanding in-house packaging often appears to be the logical next step. In reality, building new capacity requires significant capital investment, long lead times, and ongoing fixed operational costs.
Partnering with PCI offers an alternative approach. By leveraging existing commercial infrastructure and expertise, companies gain the flexibility to scale without delaying critical launch and growth milestones. PCI enables organizations to respond to demand variability, portfolio changes, and market expansion while reducing financial and operational risk.
Partnering with PCI allows you to buy flexibility instead of building risk.
With PCI, you gain:
Accelerated timelines
to meet launch and growth milestones
Reduced capital expenditure
and balance-sheet impact
Scalable capacity
that grows with your product lifecycle
Optionality
to respond to demand volatility and portfolio change
Dedicated Line Builds & Complex Capital Projects - Executed by Experts
For programs requiring long-term, high-volume, or product-specific solutions, PCI goes beyond standard outsourcing. PCI has deep experience delivering dedicated line builds and complex capital projects within our global facilities, tailored to specific product, process, and volume requirements.
This approach allows our client partners to maintain strategic oversight and product control while we manage the design, build, validation, and execution of technically demanding packaging solutions, accelerating timelines and reducing execution risk.
A Proven CDMO Partnerfor Commercial Success
PCI helps ensure packaging capacity never limits patient access to treatments and is a trusted solution provider combining:
Over 50 years of commercial packaging expertise
A global footprint with local execution delivering life-changing therapies where needed
Deep experience supporting lifecycle transitions from clinical to commercial
A relentless focus on quality, reliability, and patient impact
When internal capacity limits growth, PCI helps you move faster, invest smarter, and stay flexible so your teams can focus on what matters most: delivering life-changing therapies to patients worldwide.
Sterile Commercial Packaging Technology
Committing our capacity to the right molecules, science, and partners, our precision isn't reserved for scale, it's built into everything we do.